1-20 of 77
lipoproteins, vldl
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Erratum. Long Noncoding RNA lncRHL Regulates Hepatic VLDL Secretion by Modulating hnRNPU/BMAL1/MTTP Axis. Diabetes 2022;71:1915–1928

Xuan Shen, Yajun Zhang, Xuetao Ji, Bo Li, Yuzhu Wang, Yun Huang, Xu Zhang, Jingxian Yu, Ruihan Zou, Dongdong Qin, Hongwen Zhou, Qian Wang, John Zhong Li
Journal: Diabetes
Diabetes 2023;72(6):819
DOI: https://doi.org/10.2337/db23-er06
Published: 03 April 2023
View article titled, Erratum. Long Noncoding RNA lncRHL Regulates Hepatic VLDL Secretion by Modulating hnRNPU/BMAL1/MTTP Axis. Diabetes 2022;71:1915–1928
Click here to open pdf in another window PDF for Erratum. Long Noncoding RNA lncRHL Regulates Hepatic VLDL Secretion by Modulating hnRNPU/BMAL1/MTTP Axis. Diabetes 2022;71:1915–1928
Journal Articles

Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)

Sara Heebøll, Jeyanthini Risikesan, Steffen Ringgaard, Indumathi Kumarathas, Thomas D. Sandahl, Henning Grønbæk, Esben Søndergaard, Søren Nielsen
Journal: Diabetes
Diabetes 2022;71(11):2402–2411
DOI: https://doi.org/10.2337/db22-0313
Published: 24 August 2022
View article titled, Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
Click here to open pdf in another window PDF for Impaired Glucagon-Mediated Suppression of VLDL-Triglyceride Secretion in Individuals With Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD)
Journal Articles

Long Noncoding RNA lncRHPL Regulates Hepatic VLDL Secretion by Modulating hnRNPU/BMAL1/MTTP Axis

Xuan Shen, Yajun Zhang, Xuetao Ji, Bo Li, Yuzhu Wang, Yun Huang, Xu Zhang, Jingxian Yu, Ruihan Zou, Dongdong Qin, Hongwen Zhou, Qian Wang, John Zhong Li
Journal: Diabetes
Diabetes 2022;71(9):1915–1928
DOI: https://doi.org/10.2337/db21-1145
Published: 30 June 2022
View article titled, Long Noncoding RNA lncRHPL Regulates Hepatic VLDL Secretion by Modulating hnRNPU/BMAL1/MTTP Axis
Click here to open pdf in another window PDF for Long Noncoding RNA lncRHPL Regulates Hepatic VLDL Secretion by Modulating hnRNPU/BMAL1/MTTP Axis
Meeting Abstracts

276-OR: Impaired Glucagon-Mediated Suppression of VLDL-TG Secretion in Individuals with MAFLD

SARA HEEBØLL, JEYANTHINI R. RISIKESAN, HENNING GRONBAEK, ESBEN SØNDERGAARD, SØREN NIELSEN
Journal: Diabetes
Diabetes 2022;71(Supplement_1):276-OR
DOI: https://doi.org/10.2337/db22-276-OR
Published: 01 June 2022
View article titled, 276-OR: Impaired Glucagon-Mediated Suppression of VLDL-TG Secretion in Individuals with MAFLD
Journal Articles

A New Treatment Strategy for Diabetic Dyslipidemia?

Vishal Kothari, Karin E. Bornfeldt
Journal: Diabetes
Diabetes 2020;69(10):2061–2063
DOI: https://doi.org/10.2337/dbi20-0035
Published: 15 September 2020
View article titled, A New Treatment Strategy for Diabetic Dyslipidemia?
Click here to open pdf in another window PDF for A New Treatment Strategy for Diabetic Dyslipidemia?
Meeting Abstracts

1051-P: Selective Targeting of Angiopoietin-Like 3 (ANGPTL3) via the Second-Generation Antisense Oligonucleotide (ASO) ISIS-703802 (AKCEA-ANGPTL3-LRx) in Subjects with Familial Partial Lipodystrophy (FPLD)

MARIA CRISTINA FOSS-FREITAS, BARIS AKINCI, ADAM H. NEIDERT, RITA P. HENCH, MARIO SWAIDAN, ELIF A. ORAL
Journal: Diabetes
Diabetes 2020;69(Supplement_1):1051-P
DOI: https://doi.org/10.2337/db20-1051-P
Published: 01 June 2020
View article titled, 1051-P: Selective Targeting of Angiopoietin-Like 3 (ANGPTL3) via the Second-Generation Antisense Oligonucleotide (ASO) ISIS-703802 (AKCEA-ANGPTL3-LRx) in Subjects with Familial Partial Lipodystrophy (FPLD)
Journal Articles

Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease

Alan Chait, Henry N. Ginsberg, Tomas Vaisar, Jay W. Heinecke, Ira J. Goldberg, Karin E. Bornfeldt
Journal: Diabetes
Diabetes 2020;69(4):508–516
DOI: https://doi.org/10.2337/dbi19-0007
Published: 16 March 2020
View article titled, Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease
Click here to open pdf in another window PDF for Remnants of the Triglyceride-Rich Lipoproteins, Diabetes, and Cardiovascular Disease
Meeting Abstracts

1844-P: Long-Term Remission of Type 2 Diabetes after Weight Loss Requires Effective Clearance of Hepatic VLDL-TG and Maintenance of Low Intrapancreatic Fat

AHMAD AL-MRABEH, SVIATLANA V. ZHYZHNEUSKAYA, ALISON C. BARNES, KIEREN G. HOLLINGSWORTH, NAVEED SATTAR, MICHAEL E. LEAN, ROY TAYLOR
Journal: Diabetes
Diabetes 2019;68(Supplement_1):1844-P
DOI: https://doi.org/10.2337/db19-1844-P
Published: 01 June 2019
View article titled, 1844-P: Long-Term Remission of Type 2 Diabetes after Weight Loss Requires Effective Clearance of Hepatic VLDL-TG and Maintenance of Low Intrapancreatic Fat
Meeting Abstracts

Roles of Adipose Tissue VLDL-VLDLR Axis in Energy Metabolism

JAE BUM KIM, KYUNG CHEUL SHIN, INJAE HWANG, SUNG SIK CHOE
Journal: Diabetes
Diabetes 2018;67(Supplement_1):1951-P
DOI: https://doi.org/10.2337/db18-1951-P
Published: 01 July 2018
View article titled, Roles of Adipose Tissue VLDL-VLDLR Axis in Energy Metabolism
Journal Articles

Fasting Plasma Insulin Concentrations Are Associated With Changes in Hepatic Fatty Acid Synthesis and Partitioning Prior to Changes in Liver Fat Content in Healthy Adults

Camilla Pramfalk, Michael Pavlides, Rajarshi Banerjee, Catriona A. McNeil, Stefan Neubauer, Fredrik Karpe, Leanne Hodson
Journal: Diabetes
Diabetes 2016;65(7):1858–1867
DOI: https://doi.org/10.2337/db16-0236
Published: 19 April 2016
View article titled, Fasting Plasma Insulin Concentrations Are Associated With Changes in Hepatic Fatty Acid Synthesis and Partitioning Prior to Changes in Liver Fat Content in Healthy Adults
Click here to open pdf in another window PDF for Fasting Plasma Insulin Concentrations Are Associated With Changes in Hepatic Fatty Acid Synthesis and Partitioning Prior to Changes in Liver Fat Content in Healthy Adults
Includes: Supplementary data
Journal Articles

Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain

Thomas Scherer, Claudia Lindtner, James O’Hare, Martina Hackl, Elizabeth Zielinski, Angelika Freudenthaler, Sabina Baumgartner-Parzer, Klaus Tödter, Joerg Heeren, Martin Krššák, Ludger Scheja, Clemens Fürnsinn, Christoph Buettner
Journal: Diabetes
Diabetes 2016;65(6):1511–1520
DOI: https://doi.org/10.2337/db15-1552
Published: 09 February 2016
View article titled, Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain
Click here to open pdf in another window PDF for Insulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain
Includes: Supplementary data
Journal Articles

PET Measurements of Organ Metabolism: The Devil Is in the Details

Kooresh I. Shoghi, Robert J. Gropler
Journal: Diabetes
Diabetes 2015;64(7):2332–2334
DOI: https://doi.org/10.2337/db15-0226
Published: 17 June 2015
View article titled, PET Measurements of Organ Metabolism: The Devil Is in the Details
Click here to open pdf in another window PDF for PET Measurements of Organ Metabolism: The Devil Is in the Details
Journal Articles

Metformin Lowers Plasma Triglycerides by Promoting VLDL-Triglyceride Clearance by Brown Adipose Tissue in Mice

Janine J. Geerling, Mariëtte R. Boon, Gerard C. van der Zon, Sjoerd A.A. van den Berg, Anita M. van den Hoek, Marc Lombès, Hans M.G. Princen, Louis M. Havekes, Patrick C.N. Rensen, Bruno Guigas
Journal: Diabetes
Diabetes 2014;63(3):880–891
DOI: https://doi.org/10.2337/db13-0194
Published: 13 February 2014
View article titled, Metformin Lowers Plasma Triglycerides by Promoting VLDL-Triglyceride Clearance by Brown Adipose Tissue in Mice
Click here to open pdf in another window PDF for Metformin Lowers Plasma Triglycerides by Promoting VLDL-Triglyceride Clearance by Brown Adipose Tissue in Mice
Includes: Supplementary data
Journal Articles

Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol. Diabetes 2013;62: 4063–4069

Fariba Shojaee-Moradie, Yuying Ma, Shaoying Lou, Roman Hovorka, A. Margot Umpleby
Journal: Diabetes
Diabetes 2014;63(2):815
DOI: https://doi.org/10.2337/db14-er02a
Published: 16 January 2014
View article titled, Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol. Diabetes 2013;62: 4063–4069
Click here to open pdf in another window PDF for Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol. Diabetes 2013;62: 4063–4069
Journal Articles

Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol

Fariba Shojaee-Moradie, Yuying Ma, Shaoying Lou, Roman Hovorka, A. Margot Umpleby
Journal: Diabetes
Diabetes 2013;62(12):4063–4069
DOI: https://doi.org/10.2337/db13-0935
Published: 16 November 2013
View article titled, Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol
Click here to open pdf in another window PDF for Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol
Journal Articles

Systemic Free Fatty Acid Disposal Into Very Low-Density Lipoprotein Triglycerides

Christina Koutsari, Manpreet S. Mundi, Asem H. Ali, Bruce W. Patterson, Michael D. Jensen
Journal: Diabetes
Diabetes 2013;62(7):2386–2395
DOI: https://doi.org/10.2337/db12-1557
Published: 14 June 2013
View article titled, Systemic Free Fatty Acid Disposal Into Very Low-Density Lipoprotein Triglycerides
Click here to open pdf in another window PDF for Systemic Free Fatty Acid Disposal Into Very Low-Density Lipoprotein Triglycerides
Journal Articles

VASP Increases Hepatic Fatty Acid Oxidation by Activating AMPK in Mice

Sanshiro Tateya, Norma Rizzo-De Leon, Priya Handa, Andrew M. Cheng, Vicki Morgan-Stevenson, Kayoko Ogimoto, Jenny E. Kanter, Karin E. Bornfeldt, Guenter Daum, Alexander W. Clowes, Alan Chait, Francis Kim
Journal: Diabetes
Diabetes 2013;62(6):1913–1922
DOI: https://doi.org/10.2337/db12-0325
Published: 17 May 2013
View article titled, VASP Increases Hepatic Fatty Acid Oxidation by Activating AMPK in Mice
Click here to open pdf in another window PDF for VASP Increases Hepatic Fatty Acid Oxidation by Activating AMPK in Mice
Includes: Supplementary data
Journal Articles

Independent Effects of Testosterone on Lipid Oxidation and VLDL-TG Production: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

Christian Høst, Lars C. Gormsen, Britt Christensen, Niels Jessen, David M. Hougaard, Jens S. Christiansen, Steen B. Pedersen, Michael D. Jensen, Søren Nielsen, Claus H. Gravholt
Journal: Diabetes
Diabetes 2013;62(5):1409–1416
DOI: https://doi.org/10.2337/db12-0440
Published: 16 April 2013
View article titled, Independent Effects of Testosterone on Lipid Oxidation and VLDL-TG Production: <span class="subtitle">A Randomized, Double-Blind, Placebo-Controlled, Crossover Study</span>
Click here to open pdf in another window PDF for Independent Effects of Testosterone on Lipid Oxidation and VLDL-TG Production: <span class="subtitle">A Randomized, Double-Blind, Placebo-Controlled, Crossover Study</span>
Includes: Supplementary data
Journal Articles

Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes

Gerald F. Watts, Dick C. Chan
Journal: Diabetes
Diabetes 2013;62(2):336–338
DOI: https://doi.org/10.2337/db12-1098
Published: 17 January 2013
View article titled, Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes
Click here to open pdf in another window PDF for Novel Insights Into the Regulation of Postprandial Lipemia by Glucagon-Like Peptides: Significance for Diabetes
Journal Articles

Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System

Eveline Bruinstroop, Lei Pei, Mariëtte T. Ackermans, Ewout Foppen, Anke J. Borgers, Joan Kwakkel, Anneke Alkemade, Eric Fliers, Andries Kalsbeek
Journal: Diabetes
Diabetes 2012;61(5):1043–1050
DOI: https://doi.org/10.2337/db11-1142
Published: 13 April 2012
View article titled, Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
Click here to open pdf in another window PDF for Hypothalamic Neuropeptide Y (NPY) Controls Hepatic VLDL-Triglyceride Secretion in Rats via the Sympathetic Nervous System
Includes: Supplementary data